Explore more publications!
Iowa Healthcare Reporter
Got News to Share?

Iowa Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iowa Healthcare Reporter.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on November 3, 2025

ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
November 3, 2025

ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting

Indeterminate GlobeNewswire
Kailera Therapeutics Appoints Frank Clyburn to Board of Directors
November 3, 2025

Kailera Therapeutics Appoints Frank Clyburn to Board of Directors

Indeterminate GlobeNewswire
Apogee Therapeutics to Participate in Upcoming Conferences
November 3, 2025

Apogee Therapeutics to Participate in Upcoming Conferences

Indeterminate GlobeNewswire
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025
November 3, 2025

Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025

Indeterminate GlobeNewswire
Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
November 3, 2025

Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

Indeterminate GlobeNewswire
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
November 3, 2025

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences

Indeterminate GlobeNewswire
BridgeBio to Present Data from the Overall ATTR-CM Variant and V142I (V122I) Populations from ATTRibute-CM at the AHA Scientific Sessions 2025
November 3, 2025

BridgeBio to Present Data from the Overall ATTR-CM Variant and V142I (V122I) Populations from ATTRibute-CM at the AHA Scientific Sessions 2025

Indeterminate GlobeNewswire
Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder
November 3, 2025

Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder

Indeterminate GlobeNewswire
Dyne Therapeutics to Present at Upcoming Investor Conferences
November 3, 2025

Dyne Therapeutics to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 3, 2025

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301
November 3, 2025

Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301

Indeterminate GlobeNewswire
Kraig Biocraft Laboratories Confirms Spider Silk Production Operations Unaffected by Southeast Asia Typhoons due to Strategic Relocations to Highland Over Last 24 Months
November 3, 2025

Kraig Biocraft Laboratories Confirms Spider Silk Production Operations Unaffected by Southeast Asia Typhoons due to Strategic Relocations to Highland Over Last 24 Months

Indeterminate GlobeNewswire
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
November 3, 2025

uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease

Indeterminate GlobeNewswire
New Report Reveals Disconnect Between Short-Term Focus and Long-Term, Data-Backed Growth Strategies for Health Systems
November 3, 2025

New Report Reveals Disconnect Between Short-Term Focus and Long-Term, Data-Backed Growth Strategies for Health Systems

Indeterminate GlobeNewswire
Neumora Therapeutics to Participate in Upcoming Conferences in November
November 3, 2025

Neumora Therapeutics to Participate in Upcoming Conferences in November

Indeterminate GlobeNewswire
Climb Bio to Present at Upcoming Investor Conferences
November 3, 2025

Climb Bio to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire
Avalo Therapeutics to Participate in Upcoming Investor Conferences
November 3, 2025

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Arvinas to Participate in Upcoming Investor Conferences
November 3, 2025

Arvinas to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler
November 3, 2025

Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler

Indeterminate GlobeNewswire
Renforcer l’impact positif dans les communautés grâce au hockey : le concours « Entraînez-vous avec un pro » de Dr. Oetker - Giuseppe Pizzeria est de retour pour une 4e année
November 3, 2025

Renforcer l’impact positif dans les communautés grâce au hockey : le concours « Entraînez-vous avec un pro » de Dr. Oetker - Giuseppe Pizzeria est de retour pour une 4e année

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions